Maternal creatine in pregnancy

a retrospective cohort study

H. Dickinson, M. Davies-Tuck, S. J. Ellery, J. A. Grieger, E. M. Wallace, R. J. Snow, D. W. Walker, V. L. Clifton

Research output: Contribution to journalArticleResearchpeer-review

6 Citations (Scopus)

Abstract

Objective: To estimate creatine concentrations in maternal plasma and urine, and establish relationships with maternal characteristics, diet and fetal growth. Design: Retrospective cohort study. Setting: Lyell McEwin Hospital, Adelaide, Australia. Population: A biobank of plasma and urine samples collected at 13, 18, 30 and 36 weeks’ gestation from 287 pregnant women from a prospective cohort of asthmatic and non-asthmatic women. Methods: Creatine was measured by enzymatic analysis. Change in creatine over pregnancy was assessed using the Friedman test. Linear mixed models regression was used to determine associations between maternal factors and diet with creatine across pregnancy and between creatine with indices of fetal growth at birth. Main outcome measures: Maternal creatine concentrations, associations between maternal factors and creatine and between creatine and fetal growth parameters. Results: Maternal smoking, body mass index, asthma and socio-economic status were positively and parity negatively associated with maternal plasma and/or urine creatine. Maternal urine creatine concentration was positively associated with birthweight centile and birth length. After adjustment, each μmol/l increase in maternal urinary creatine was associated with a 1.23 (95% CI 0.44–2.02) unit increase in birthweight centile and a 0.11-cm (95% CI 0.03–0.2) increase in birth length. Conclusions: Maternal factors and fetal growth measures are associated with maternal plasma and urine creatine concentrations. Tweetable abstract: Maternal creatine is altered by pregnancy; fetal growth measures are associated with maternal creatine concentrations.

Original languageEnglish
Pages (from-to)1830-1838
Number of pages9
JournalBJOG: an International Journal of Obstetrics and Gynaecology
Volume123
Issue number11
DOIs
Publication statusPublished - 1 Oct 2016

Keywords

  • Fetal growth
  • phosphocreatine
  • placenta

Cite this

@article{256f2a64c37841fdbb731b316ed364f7,
title = "Maternal creatine in pregnancy: a retrospective cohort study",
abstract = "Objective: To estimate creatine concentrations in maternal plasma and urine, and establish relationships with maternal characteristics, diet and fetal growth. Design: Retrospective cohort study. Setting: Lyell McEwin Hospital, Adelaide, Australia. Population: A biobank of plasma and urine samples collected at 13, 18, 30 and 36 weeks’ gestation from 287 pregnant women from a prospective cohort of asthmatic and non-asthmatic women. Methods: Creatine was measured by enzymatic analysis. Change in creatine over pregnancy was assessed using the Friedman test. Linear mixed models regression was used to determine associations between maternal factors and diet with creatine across pregnancy and between creatine with indices of fetal growth at birth. Main outcome measures: Maternal creatine concentrations, associations between maternal factors and creatine and between creatine and fetal growth parameters. Results: Maternal smoking, body mass index, asthma and socio-economic status were positively and parity negatively associated with maternal plasma and/or urine creatine. Maternal urine creatine concentration was positively associated with birthweight centile and birth length. After adjustment, each μmol/l increase in maternal urinary creatine was associated with a 1.23 (95{\%} CI 0.44–2.02) unit increase in birthweight centile and a 0.11-cm (95{\%} CI 0.03–0.2) increase in birth length. Conclusions: Maternal factors and fetal growth measures are associated with maternal plasma and urine creatine concentrations. Tweetable abstract: Maternal creatine is altered by pregnancy; fetal growth measures are associated with maternal creatine concentrations.",
keywords = "Fetal growth, phosphocreatine, placenta",
author = "H. Dickinson and M. Davies-Tuck and Ellery, {S. J.} and Grieger, {J. A.} and Wallace, {E. M.} and Snow, {R. J.} and Walker, {D. W.} and Clifton, {V. L.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1111/1471-0528.14237",
language = "English",
volume = "123",
pages = "1830--1838",
journal = "BJOG: an International Journal of Obstetrics and Gynaecology",
issn = "1470-0328",
publisher = "Wiley-Blackwell",
number = "11",

}

Maternal creatine in pregnancy : a retrospective cohort study. / Dickinson, H.; Davies-Tuck, M.; Ellery, S. J.; Grieger, J. A.; Wallace, E. M.; Snow, R. J.; Walker, D. W.; Clifton, V. L.

In: BJOG: an International Journal of Obstetrics and Gynaecology, Vol. 123, No. 11, 01.10.2016, p. 1830-1838.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Maternal creatine in pregnancy

T2 - a retrospective cohort study

AU - Dickinson, H.

AU - Davies-Tuck, M.

AU - Ellery, S. J.

AU - Grieger, J. A.

AU - Wallace, E. M.

AU - Snow, R. J.

AU - Walker, D. W.

AU - Clifton, V. L.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Objective: To estimate creatine concentrations in maternal plasma and urine, and establish relationships with maternal characteristics, diet and fetal growth. Design: Retrospective cohort study. Setting: Lyell McEwin Hospital, Adelaide, Australia. Population: A biobank of plasma and urine samples collected at 13, 18, 30 and 36 weeks’ gestation from 287 pregnant women from a prospective cohort of asthmatic and non-asthmatic women. Methods: Creatine was measured by enzymatic analysis. Change in creatine over pregnancy was assessed using the Friedman test. Linear mixed models regression was used to determine associations between maternal factors and diet with creatine across pregnancy and between creatine with indices of fetal growth at birth. Main outcome measures: Maternal creatine concentrations, associations between maternal factors and creatine and between creatine and fetal growth parameters. Results: Maternal smoking, body mass index, asthma and socio-economic status were positively and parity negatively associated with maternal plasma and/or urine creatine. Maternal urine creatine concentration was positively associated with birthweight centile and birth length. After adjustment, each μmol/l increase in maternal urinary creatine was associated with a 1.23 (95% CI 0.44–2.02) unit increase in birthweight centile and a 0.11-cm (95% CI 0.03–0.2) increase in birth length. Conclusions: Maternal factors and fetal growth measures are associated with maternal plasma and urine creatine concentrations. Tweetable abstract: Maternal creatine is altered by pregnancy; fetal growth measures are associated with maternal creatine concentrations.

AB - Objective: To estimate creatine concentrations in maternal plasma and urine, and establish relationships with maternal characteristics, diet and fetal growth. Design: Retrospective cohort study. Setting: Lyell McEwin Hospital, Adelaide, Australia. Population: A biobank of plasma and urine samples collected at 13, 18, 30 and 36 weeks’ gestation from 287 pregnant women from a prospective cohort of asthmatic and non-asthmatic women. Methods: Creatine was measured by enzymatic analysis. Change in creatine over pregnancy was assessed using the Friedman test. Linear mixed models regression was used to determine associations between maternal factors and diet with creatine across pregnancy and between creatine with indices of fetal growth at birth. Main outcome measures: Maternal creatine concentrations, associations between maternal factors and creatine and between creatine and fetal growth parameters. Results: Maternal smoking, body mass index, asthma and socio-economic status were positively and parity negatively associated with maternal plasma and/or urine creatine. Maternal urine creatine concentration was positively associated with birthweight centile and birth length. After adjustment, each μmol/l increase in maternal urinary creatine was associated with a 1.23 (95% CI 0.44–2.02) unit increase in birthweight centile and a 0.11-cm (95% CI 0.03–0.2) increase in birth length. Conclusions: Maternal factors and fetal growth measures are associated with maternal plasma and urine creatine concentrations. Tweetable abstract: Maternal creatine is altered by pregnancy; fetal growth measures are associated with maternal creatine concentrations.

KW - Fetal growth

KW - phosphocreatine

KW - placenta

UR - http://www.scopus.com/inward/record.url?scp=84988359579&partnerID=8YFLogxK

U2 - 10.1111/1471-0528.14237

DO - 10.1111/1471-0528.14237

M3 - Article

VL - 123

SP - 1830

EP - 1838

JO - BJOG: an International Journal of Obstetrics and Gynaecology

JF - BJOG: an International Journal of Obstetrics and Gynaecology

SN - 1470-0328

IS - 11

ER -